Toxocariasis. Fascioliasis. Etiology, epidemiology, pathogenesis, sign and symptoms, diagnosis, differential diagnosis, treatment, prevention

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Good data coming in. I need more content on fascioliasis (pathogenesis, diagnosis, treatment, prevention) and more on toxocariasis treatment/prevention. Let me read more sections.
Reading File
Reading File
Reading File
Excellent data. Now let me read the remaining fascioliasis content (more pathogenesis, differential diagnosis, prevention) and the fascioliasis section from Goldman-Cecil medicine for more detail on epidemiology/pathogenesis.
Reading File
Reading File
Reading File
I now have comprehensive data from multiple authoritative sources. Let me also quickly fetch the Red Book fascioliasis content and the Goldman-Cecil fascioliasis prevention info.
Reading File
Reading File
I now have all the essential information needed for a comprehensive answer. Let me also look at prevention for fascioliasis from the Goldman-Cecil text.
Finding Sources
I have comprehensive data from multiple authoritative sources. Here is the full synthesized answer:

TOXOCARIASIS

Etiology

Toxocariasis is caused by Toxocara canis (dog roundworm) and, less frequently, Toxocara cati (cat ascarid). These are nematode parasites — T. canis accounts for the majority of human cases. Humans are accidental (dead-end) hosts; the parasite cannot complete its adult life cycle in humans. — Goldman-Cecil Medicine, p. 1186

Epidemiology

  • Global distribution, with 5% seroprevalence in the US population ≥6 years old.
  • Visceral larva migrans (VLM) occurs most commonly in children <5 years; ocular larva migrans (OLM) typically affects older children aged 5–10 years and adolescents.
  • Risk is higher in dog/cat owners, people living in poverty, and in hot/humid regions where eggs remain viable in soil.
  • Transmission: Ingestion of embryonated eggs from soil contaminated with dog or cat feces (sandboxes, playgrounds). Direct contact with animals is not required — eggs are not infectious immediately when shed, becoming infective after 2–4 weeks in the environment.
  • Eggs may persist long-term in soil. — Red Book 2021, p. 1179

Pathogenesis

After ingestion, Toxocara larvae hatch, penetrate the intestinal wall, and enter the vasculature. Unlike in their natural hosts, larvae cannot complete the life cycle in humans — they migrate throughout the body (liver, lungs, CNS, eyes) but cannot develop into adult worms. When larvae eventually die, they induce immediate-type and delayed-type hypersensitivity reactions, resulting in eosinophilic granuloma formation. VLM and OLM appear to be mutually exclusive syndromes. — Goldman-Cecil Medicine, p. 1196

Signs and Symptoms

Most infections are asymptomatic (covert toxocariasis = persistent eosinophilia only).
SyndromeFeatures
Visceral Larva Migrans (VLM)Low-grade fever, cough, wheezing, hepatosplenomegaly, abdominal pain, malaise, urticaria; symptoms appear gradually and resolve over 4–8 weeks
NeurotoxocariasisEosinophilic meningoencephalitis, seizures, encephalopathy, myelitis, cerebral vasculitis, space-occupying lesions, neuropsychiatric symptoms
Ocular Larva Migrans (OLM)Unilateral vision loss; uveitis, endophthalmitis, retinal granulomas, strabismus; usually without systemic signs
RareMyocarditis, nephritis
Laboratory findings: Marked leukocytosis, eosinophilia, hypergammaglobulinemia, occasionally anemia; elevated isohemagglutinin titers to A and B blood group antigens in VLM. — Goldman-Cecil Medicine, p. 1201; Red Book 2021, p. 1179

Diagnosis

  • Clinical context: Compatible presentation + history of dog/cat exposure.
  • Serology (ELISA ± immunoblot): Detection of antibodies to Toxocara larval-stage antigens — preferred method. Available through the CDC in the US. Does not distinguish active from past infection; less sensitive for OLM.
  • Imaging: Liver ultrasound, CT, or MRI may reveal diffuse nodular lesions <2 cm in VLM. CT and fluorescein angiography help assess OLM and distinguish from retinoblastoma.
  • Vitreous fluid: Elevated anti-Toxocara antibody levels relative to serum — suggestive of OLM.
  • Liver biopsy: Diagnostic if larvae are identified microscopically, but low sensitivity — rarely indicated.
  • PCR: Not currently available. — Goldman-Cecil Medicine, p. 1208; Red Book 2021, p. 1180

Differential Diagnosis

FormMain Differentials
VLMAscariasis, other helminth infections, hypereosinophilic syndrome, acute leukemia, sarcoidosis
NeurotoxocariasisBacterial/viral meningoencephalitis, eosinophilic meningitis (Angiostrongylus), CNS tumors, tuberculosis
OLMRetinoblastoma (most important), ocular tuberculosis, toxoplasmosis, Coats' disease, endophthalmitis
OLM involving the retina can be particularly difficult to distinguish from retinoblastoma. CT and fluorescein angiography are critical differentiators. — Goldman-Cecil Medicine, p. 1203

Treatment

IndicationRegimen
Acute VLMAlbendazole 400 mg twice daily × 5 days
Severe VLM (cardiac, pulmonary, neurologic involvement)Albendazole + corticosteroids (prednisone 60 mg/day × 5 days)
OLMCorticosteroids (oral/topical) ± albendazole ± vitrectomy (combination with specialist supervision)
  • Mebendazole is an alternative to albendazole.
  • Albendazole is FDA-approved (though not specifically for this indication) and has been used safely in children as young as 1 year. — Goldman-Cecil Medicine, p. 1215; Red Book 2021, p. 1180

Prevention

  • Periodic anthelmintic deworming of dogs and cats (especially puppies and kittens) — reduces environmental egg burden.
  • Proper disposal of pet feces.
  • Cover sandboxes when not in use.
  • Handwashing after contact with dogs/cats or soil.
  • Keep children from playing in areas contaminated with animal feces.
  • No post-exposure prophylaxis is recommended for asymptomatic contacts. — Goldman-Cecil Medicine, p. 1247; Red Book 2021, p. 1181

FASCIOLIASIS

Etiology

Fascioliasis is caused by Fasciola hepatica (adult: 30 × 13 mm) or F. gigantica (adult: 75 × 20 mm), liver flukes (trematodes). The most common definitive hosts are cattle, sheep, and goats; humans are incidental hosts. — Goldman-Cecil Medicine, p. 569

Epidemiology

  • Cosmopolitan distribution — affects >70 countries. WHO estimates 2.4–2.6 million people infected globally, with the highest prevalence (>60%) in Peru and Bolivia; also prevalent in South America, Africa, and Asia.
  • F. hepatica is found in the Americas, Europe, and Oceania; F. gigantica is additionally found in Africa and Asia.
  • Women have higher incidence with more severe disease than men.
  • Transmission: Ingestion of aquatic vegetation (watercress, water lettuce, alfalfa, mint, parsley, khat) containing encysted metacercariae, or drinking contaminated fresh water. — Goldman-Cecil Medicine, pp. 569, 591; Tietz Textbook of Laboratory Medicine, p. 3598

Pathogenesis (Life Cycle)

  1. Eggs in stool are deposited in water → miracidia hatch in 9–14 days → infect freshwater snails (Lymnaea spp., first intermediate host) → develop through sporocysts, rediae, cercariae (4–7 weeks in snail).
  2. Free-swimming cercariae are released → attach to aquatic vegetation as metacercariae (the infective stage for humans).
  3. After ingestion, metacercariae excyst in the duodenum → penetrate intestinal wall → cross peritoneal cavity → reach the liver in ~4 weeks → penetrate Glisson's capsule → migrate through liver parenchyma (causing inflammation, hemorrhage, granulomas, track-like lesions) → reach bile ducts at 3–5 months.
  4. Adults mature and reside in hepatic/common bile ducts and gallbladder for up to 13 years, producing eggs that exit via the sphincter of Oddi → stool.
Pathology of bile ducts: Dilated, thick-walled, calcareous bile ducts with marked fibrosis; hyperplasia of ductal epithelium. — Goldman-Cecil Medicine, pp. 598–604

Signs and Symptoms

Symptoms depend on disease phase:

Acute (Invasive/Migratory) Phase — first 3–5 months

  • Prolonged fever, hepatomegaly, right upper quadrant/epigastric pain
  • Marked peripheral eosinophilia (hallmark)
  • Anorexia, weight loss, nausea, vomiting, diarrhea (2–5 days before liver invasion)
  • Urticaria, cough, lymphadenopathy, arthralgias
  • Occasional subcapsular liver hematoma (intense hemorrhage)
  • CT: Multiple migrating hypodense lesions (resembling metastases) — change position over time
  • Hyperbilirubinemia notably absent in this phase
  • Ectopic larvae may reach subcutaneous tissue, pancreas, eye, brain, lung, stomach wall

Chronic (Obstructive/Biliary) Phase — after adult worm establishment

  • Biliary obstruction: Colicky right upper quadrant pain, cholangitis, cholelithiasis
  • Elevated alkaline phosphatase; eosinophilia absent in ~50% of cases
  • Bacterial superinfection → cholangitis, liver abscess
  • Hemobilia, liver fibrosis
  • ERCP may reveal adult worms in the bile duct
Goldman-Cecil Medicine, pp. 598–604; Tietz Textbook, p. 3854

Diagnosis

Acute Phase

  • Cathepsin L1-based antibody ELISA (sensitivity 92%, specificity 84%) — first-line serologic test; antibodies detectable within 2–4 weeks of infection.
  • If serology unavailable: CT (track-like hepatic lesions) ± liver biopsy (to exclude metastases).
  • Stool examination is negative in the acute phase (eggs not yet present).
  • A trial of triclabendazole with clinical/eosinophilia resolution can serve as a diagnostic criterion when serology and CT are unavailable.

Chronic Phase

  • Stool examination (≥3 samples): Lumbreras rapid sedimentation technique or Kato-Katz technique — identifies large, unembryonated, yellow-brown, operculate eggs (130–150 × 63–90 μm); eggs appear in stool 5–7 weeks after infection.
    • ⚠️ Spurious passage: Eggs in stool may result from ingesting infected cattle/sheep liver (not true infection) — confirm by history and repeat stool after meat-free diet.
  • Serology helpful if stool negative; sensitivity >95% with ES-antigen EIA.
  • ERCP: Can visualize and retrieve adult worms; useful for biliary obstruction.
  • Liver biopsy: May show flukes migrating through parenchyma (with eosinophilic granulomas/fibrosis); differentiated from Clonorchis/Opisthorchis by larger size, cuticular spines, multiple intestinal branches in cross-section.
  • In the US, serologic testing available at the CDC.
Goldman-Cecil Medicine, pp. 692–694; Tietz Textbook, pp. 3865–3873; Henry's Clinical Diagnosis, p. 1538

Differential Diagnosis

PhaseMain Differentials
Acute fascioliasisAcute cholecystitis, hepatic metastases, liver abscess (pyogenic/amoebic), viral hepatitis, schistosomiasis, hypereosinophilic syndrome
Chronic fascioliasisPrimary sclerosing cholangitis, choledocholithiasis, cholangiocarcinoma, opisthorchiasis, clonorchiasis, biliary stricture
CT lesionsHepatic metastases (key distinction: fascioliasis lesions migrate/change position over time)
Acute fascioliasis is clinically similar to acute cholecystitis but is distinguished by significant eosinophilia and absence of hyperbilirubinemia. — Goldman-Cecil Medicine, p. 600

Treatment

Fascioliasis does NOT respond to praziquantel (unlike most other trematode infections).
SettingDrug / Regimen
Treatment of choiceTriclabendazole 10 mg/kg orally on 2 consecutive days
Cure rate>90%; however, treatment failures and resistance reported
FDA approvalTriclabendazole approved for fascioliasis in patients ≥6 years
MonitoringStool examination negative for ≥3 months = cure; serology may take >1 year to resolve
Drug failureRepeat rounds of triclabendazole; some infections are resistant
Biliary obstruction (from dead parasites)May require surgical or endoscopic (ERCP) intervention
Goldman-Cecil Medicine, pp. 711–713; Tietz Textbook, p. 3854

Prevention

  • Avoid eating raw aquatic plants (especially watercress) in endemic areas; cook or wash vegetation thoroughly.
  • Do not drink untreated fresh water from streams or ponds in endemic regions.
  • Veterinary control: Regular treatment of livestock (sheep, cattle, goats) with anthelmintics to reduce environmental contamination.
  • Snail control: Molluscicidal treatment of pastures and water bodies to interrupt the Lymnaea snail intermediate host cycle.
  • Public health education in endemic communities, particularly in the Andean regions of South America.
  • Improvement of sanitation to prevent fecal contamination of water sources.

Key Comparative Summary

FeatureToxocariasisFascioliasis
Causative agentToxocara canis / T. cati (nematode)Fasciola hepatica / F. gigantica (trematode)
Definitive hostDog/catSheep, cattle
TransmissionIngestion of embryonated eggs from soilIngestion of metacercariae on aquatic plants
Intermediate hostNone (eggs direct to humans)Lymnaea snail
Main organ affectedLiver, lungs, CNS, eyesLiver, bile ducts
Hallmark lab findingEosinophilia, hypergammaglobulinemiaEosinophilia (acute phase), elevated ALP
DiagnosisELISA (CDC), imagingStool eggs (chronic), ELISA (acute)
TreatmentAlbendazoleTriclabendazole (NOT praziquantel)
PreventionDeworm pets, cover sandboxesAvoid raw watercress, control snails/livestock
Sources: Goldman-Cecil Medicine (2022); Red Book 2021: Report of the Committee on Infectious Diseases; Tietz Textbook of Laboratory Medicine, 7th Ed.; Henry's Clinical Diagnosis and Management by Laboratory MethodsBoth conditions are covered comprehensively above. A few clinical pearls worth highlighting:
Toxocariasis:
  • The most critical differential for ocular larva migrans is retinoblastoma — misdiagnosis can lead to unnecessary enucleation. CT and fluorescein angiography are essential.
  • Eosinophilia is the most consistent laboratory clue; serology through the CDC is the preferred diagnostic tool.
  • Albendazole is the drug of choice; add corticosteroids for severe or neurologic/cardiac disease.
Fascioliasis:
  • Resistance to praziquantel is a unique feature — always use triclabendazole.
  • The acute phase mimics hepatic metastases on CT, but lesions change in location and morphology over serial scans because the fluke is still migrating — a key distinguishing feature.
  • Stool examination is useless in the acute phase (eggs not yet produced); serology is essential early. Stool becomes the primary test only in chronic infection.
  • Women tend to have more severe disease than men.
This is a shared conversation. Sign in to Orris to start your own chat.